PRTC

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

PureTech Health PLC

NASDAQ | PRTC

17.73

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 24, 2025)

$431.52M

Market Cap

9.8

P/E Ratio

1.7

EPS

$24.99

52 Week High

$13.30

52 Week Low

HEALTHCARE

Sector

PRTC Chart

Recent Chart
Price Action

PRTC Technicals

Tags:

PRTC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.3M
Total Revenue $4.8M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$136M
Selling General And Administrative $27M
Research And Development $54M
Operating Expenses $140M
Investment Income Net -
Net Interest Income $13M
Interest Income $23M
Interest Expense $10M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.6M
Income Before Tax $24M
Income Tax Expense -$4M
Interest And Debt Expense -
Net Income From Continuing Operations $28M
Comprehensive Income Net Of Tax -
Ebit $34M
Ebitda $37M
Net Income $54M

Revenue & Profitability

Earnings Performance

PRTC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $603M
Total Current Assets $386M
Cash And Cash Equivalents At Carrying Value $281M
Cash And Short Term Investments $281M
Inventory -
Current Net Receivables $13M
Total Non Current Assets $216M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $601K
Intangible Assets Excluding Goodwill $601K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $87M
Other Current Assets $6M
Other Non Current Assets -
Total Liabilities $195M
Total Current Liabilities $41M
Current Accounts Payable $5.5M
Deferred Revenue -
Current Debt -
Short Term Debt $7.7M
Total Non Current Liabilities $153M
Capital Lease Obligations $18M
Long Term Debt -
Current Long Term Debt $4.1M
Long Term Debt Noncurrent -
Short Long Term Debt Total $22M
Other Current Liabilities $28M
Other Non Current Liabilities $137M
Total Shareholder Equity $415M
Treasury Stock -
Retained Earnings $32M
Common Stock $4.9M
Common Stock Shares Outstanding $27M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$134M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.6M
Capital Expenditures $11K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $241M
Cashflow From Financing -$17M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$108M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $28M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.3M
Total Revenue $4.8M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$136M
Selling General And Administrative $27M
Research And Development $54M
Operating Expenses $140M
Investment Income Net -
Net Interest Income $13M
Interest Income $23M
Interest Expense $10M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.6M
Income Before Tax $24M
Income Tax Expense -$4M
Interest And Debt Expense -
Net Income From Continuing Operations $28M
Comprehensive Income Net Of Tax -
Ebit $34M
Ebitda $37M
Net Income $54M

PRTC News

PRTC Profile

PureTech Health PLC Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

PureTech Health PLC is a Boston-based clinical-stage biotherapeutics company dedicated to developing innovative therapies for complex diseases, including inflammatory, fibrotic, immune-related conditions, and various cancers affecting lymphatic and gastrointestinal systems. The company boasts a strong pipeline of drug candidates and leverages its unique research platform alongside strategic collaborations to address significant unmet medical needs. With its expertise in neurological and neuropsychological disorders, PureTech is well-positioned as a leader in delivering transformative medical solutions globally.

BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
VHAI
-50.00%
$0.00
TOVX
+0.87%
$0.34
VIVK
+11.91%
$0.29
YYAI
-14.98%
$0.07
F
+12.15%
$13.84
YDKG
-15.04%
$0.06
ASST
+27.28%
$1.10
INTC
+0.31%
$38.28
BURU
+17.26%
$0.40
CENN
-0.74%
$0.21
DVLT
+52.00%
$3.42
CGBS
-39.47%
$0.03
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+2.93%
$2.81
CJET
+27.98%
$0.11
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
ADTX
-28.06%
$0.21
PLUG
+2.43%
$2.95
T
+2.11%
$25.14
RIG
+0.25%
$3.90
SCNX
-39.61%
$1.57
NOK
+2.10%
$6.30
AMD
+7.63%
$252.92
QBTS
+5.11%
$32.65
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
GPUS
+4.19%
$0.40
WTO
-7.14%
$0.06
RF
+1.95%
$24.57
CAN
+7.38%
$1.89
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
NEHC
+48.35%
$5.86
NUAI
+48.35%
$5.86
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
GRAB
+2.27%
$5.85
QS
+14.73%
$16.82
TLRY
+0.67%
$1.49
ADAP
-7.57%
$0.06
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
AIRE
-22.42%
$0.76
ETHD
-3.52%
$3.83
JOBY
+2.93%
$16.13
ACHR
+3.48%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
RXRX
+5.41%
$6.04
BAC
+1.56%
$52.57
AMZN
+1.41%
$224.21
NIO
+0.14%
$6.90
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
BTBT
+5.10%
$3.91
RR
+12.17%
$6.08
AMC
-1.46%
$2.69
NVTS
+3.37%
$14.07
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
CLOV
+19.37%
$3.82
UUUU
+0.51%
$21.37
BTG
-0.38%
$5.21
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
0.00%
$3.35
MARA
+1.66%
$19.54
NAKA
+5.66%
$0.84
APLD
+0.14%
$33.43
CUTR
-10.19%
$0.09
PBR
-0.84%
$11.74
KDLY
+5.66%
$0.84
WU
+10.19%
$8.97
GOOGL
+2.70%
$259.92
SOUN
-1.42%
$17.98
WLGS
-5.57%
$0.04
RIVN
-0.84%
$12.98
IONQ
+1.56%
$60.30
PFE
+0.36%
$24.76
WULF
+6.44%
$13.71
VZ
+1.09%
$38.82
LAZR
+31.36%
$2.22
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
SKYQ
+9.15%
$0.50
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
SMCI
+0.77%
$48.29
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
LUMN
+3.85%
$8.09
HOOD
+4.06%
$139.79
BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
VHAI
-50.00%
$0.00
TOVX
+0.87%
$0.34
VIVK
+11.91%
$0.29
YYAI
-14.98%
$0.07
F
+12.15%
$13.84
YDKG
-15.04%
$0.06
ASST
+27.28%
$1.10
INTC
+0.31%
$38.28
BURU
+17.26%
$0.40
CENN
-0.74%
$0.21
DVLT
+52.00%
$3.42
CGBS
-39.47%
$0.03
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+2.93%
$2.81
CJET
+27.98%
$0.11
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
ADTX
-28.06%
$0.21
PLUG
+2.43%
$2.95
T
+2.11%
$25.14
RIG
+0.25%
$3.90
SCNX
-39.61%
$1.57
NOK
+2.10%
$6.30
AMD
+7.63%
$252.92
QBTS
+5.11%
$32.65
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
GPUS
+4.19%
$0.40
WTO
-7.14%
$0.06
RF
+1.95%
$24.57
CAN
+7.38%
$1.89
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
NEHC
+48.35%
$5.86
NUAI
+48.35%
$5.86
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
GRAB
+2.27%
$5.85
QS
+14.73%
$16.82
TLRY
+0.67%
$1.49
ADAP
-7.57%
$0.06
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
AIRE
-22.42%
$0.76
ETHD
-3.52%
$3.83
JOBY
+2.93%
$16.13
ACHR
+3.48%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
RXRX
+5.41%
$6.04
BAC
+1.56%
$52.57
AMZN
+1.41%
$224.21
NIO
+0.14%
$6.90
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
BTBT
+5.10%
$3.91
RR
+12.17%
$6.08
AMC
-1.46%
$2.69
NVTS
+3.37%
$14.07
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
CLOV
+19.37%
$3.82
UUUU
+0.51%
$21.37
BTG
-0.38%
$5.21
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
0.00%
$3.35
MARA
+1.66%
$19.54
NAKA
+5.66%
$0.84
APLD
+0.14%
$33.43
CUTR
-10.19%
$0.09
PBR
-0.84%
$11.74
KDLY
+5.66%
$0.84
WU
+10.19%
$8.97
GOOGL
+2.70%
$259.92
SOUN
-1.42%
$17.98
WLGS
-5.57%
$0.04
RIVN
-0.84%
$12.98
IONQ
+1.56%
$60.30
PFE
+0.36%
$24.76
WULF
+6.44%
$13.71
VZ
+1.09%
$38.82
LAZR
+31.36%
$2.22
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
SKYQ
+9.15%
$0.50
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
SMCI
+0.77%
$48.29
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
LUMN
+3.85%
$8.09
HOOD
+4.06%
$139.79
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.